Avantor, Inc. (AVTR)
NYSE: AVTR · Real-Time Price · USD
13.50
-0.16 (-1.17%)
Aug 17, 2026, 4:00 PM EDT - Market closed
Avantor Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6,561 | 6,552 | 6,784 | 6,967 | 7,512 | 7,386 |
Revenue Growth | -1.57% | -3.41% | -2.63% | -7.26% | 1.71% | 15.52% |
Gross Profit Gross Profit Growth | 2,088 | 2,139 | 2,279 | 2,364 | 2,603 | 2,503 |
Operating Income Operating Income Growth | 525.3 | 581.6 | 734.3 | 897.9 | 1,150 | 1,077 |
Net Income Net Income Growth | -578 | -530.2 | 711.5 | 321.1 | 662.3 | 508 |
Earnings Per Share EPS Growth | -0.85 | -0.78 | 1.04 | 0.47 | 1.01 | 0.85 |
EPS Growth | - | - | 121.28% | -53.49% | 18.88% | 844.44% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Laboratory Solutions Laboratory Solutions Growth | - | 4,400 | 4,610 | 4,738 | 5,002 |
Bioscience Production Bioscience Production Growth | - | 2,153 | 2,174 | 2,229 | 2,510 |
Revenue (Total) Revenue (Total) Growth | 6,561 | 6,552 | 6,784 | 6,967 | 7,512 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 306.8 | 365.4 | 262.2 | 279.5 | 399.1 | 301.7 |
Total Debt Total Debt Growth | 3,698 | 4,132 | 4,229 | 5,661 | 6,410 | 7,136 |
Net Cash (Debt) Net Cash Growth | -3,391 | -3,766 | -3,967 | -5,382 | -6,011 | -6,834 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -5.00 | -5.53 | -5.82 | -7.93 | -8.85 | -11.40 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 597 | 623.8 | 840.8 | 870 | 843.6 | 953.6 |
Capital Expenditures CapEx Growth | -142.3 | -128.8 | -148.8 | -146.4 | -133.4 | -111.1 |
Free Cash Flow Free Cash Flow Growth | 454.7 | 495 | 692 | 723.6 | 710.2 | 842.5 |
Free Cash Flow Growth | -18.20% | -28.47% | -4.37% | 1.89% | -15.70% | -2.96% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 31.82% | 32.65% | 33.60% | 33.93% | 34.65% | 33.88% |
Operating Margin | 8.01% | 8.88% | 10.82% | 12.89% | 15.31% | 14.58% |
Pretax Margin | -7.19% | -6.74% | 12.59% | 5.89% | 11.33% | 10.19% |
Profit Margin | -8.81% | -8.09% | 10.49% | 4.61% | 8.82% | 6.88% |
FCF Margin | 6.93% | 7.56% | 10.20% | 10.39% | 9.45% | 11.41% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 20.16 | 48.09 | 21.47 | 50.56 |
Forward PE | 15.65 | 12.99 | 19.60 | 22.54 | 15.35 | 28.54 |
P/FCF Ratio | 20.08 | 15.79 | 20.72 | 21.34 | 20.02 | 30.48 |
PS Ratio | 1.39 | 1.19 | 2.11 | 2.22 | 1.89 | 3.48 |